Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels.

Ata N, Dal K, Kucukazman M, Yeniova AÖ, Karakaya S, Unsal O, Dagdeviren M, Akın KO, Baser S, Beyan E, Ertugrul DT.

Open Med (Wars). 2014 Sep 17;10(1):8-13. doi: 10.1515/med-2015-0002. eCollection 2015.

2.

Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer.

Lecarpentier Y, Claes V, Vallée A, Hébert JL.

PPAR Res. 2017;2017:5879090. doi: 10.1155/2017/5879090. Epub 2017 Feb 19. Review.

3.

Colon cancer modulation by a diabetic environment: A single institutional experience.

Prieto I, Del Puerto-Nevado L, Gonzalez N, Portal-Nuñez S, Zazo S, Corton M, Minguez P, Gomez-Guerrero C, Arce JM, Sanz AB, Mas S, Aguilera O, Alvarez-Llamas G, Esbrit P, Ortiz A, Ayuso C, Egido J, Rojo F, Garcia-Foncillas J; DiabetesCancerConnect Consortium..

PLoS One. 2017 Mar 2;12(3):e0172300. doi: 10.1371/journal.pone.0172300. eCollection 2017.

4.

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.

Krönig M, Haverkamp C, Schulte A, Heinicke L, Schaal K, Drendel V, Werner M, Wetterauer U, Schultze-Seemann W, Jilg CA.

World J Surg Oncol. 2017 Feb 21;15(1):50. doi: 10.1186/s12957-017-1117-4.

5.

Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.

Hong JL, Jonsson Funk M, Buse JB, Henderson LM, Lund JL, Pate V, Stürmer T.

Epidemiology. 2017 May;28(3):446-454. doi: 10.1097/EDE.0000000000000635.

PMID:
28166101
6.

Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.

Nogami K, Muraki I, Imano H, Iso H.

BMJ Open. 2017 Jan 25;7(1):e013894. doi: 10.1136/bmjopen-2016-013894.

7.

Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer.

Chiavarina B, Nokin MJ, Bellier J, Durieux F, Bletard N, Sherer F, Lovinfosse P, Peulen O, Verset L, Dehon R, Demetter P, Turtoi A, Uchida K, Goldman S, Hustinx R, Delvenne P, Castronovo V, Bellahcène A.

Int J Mol Sci. 2017 Jan 21;18(1). pii: E213. doi: 10.3390/ijms18010213.

8.

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial.

Augustin LS, Libra M, Crispo A, Grimaldi M, De Laurentiis M, Rinaldo M, D'Aiuto M, Catalano F, Banna G, Ferrau' F, Rossello R, Serraino D, Bidoli E, Massarut S, Thomas G, Gatti D, Cavalcanti E, Pinto M, Riccardi G, Vidgen E, Kendall CW, Jenkins DJ, Ciliberto G, Montella M.

BMC Cancer. 2017 Jan 23;17(1):69. doi: 10.1186/s12885-017-3064-4.

9.

Lactate, a Neglected Factor for Diabetes and Cancer Interaction.

Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV.

Mediators Inflamm. 2016;2016:6456018. doi: 10.1155/2016/6456018. Epub 2016 Dec 18. Review.

10.

Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women.

Murphy N, Falk RT, Messinger DB, Pollak M, Xue X, Lin J, Sgueglia R, Strickler HD, Gaudet MM, Gunter MJ.

PLoS One. 2016 Dec 8;11(12):e0167832. doi: 10.1371/journal.pone.0167832. eCollection 2016.

11.

Genomics of Colorectal Cancer in African Americans.

Brim H, Ashktorab H.

Next Gener Seq Appl. 2016 Sep;3(2). pii: 133. Epub 2016 Sep 21.

13.

Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up.

Tseng CH.

PLoS One. 2016 Dec 1;11(12):e0147916. doi: 10.1371/journal.pone.0147916. eCollection 2016.

14.

Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone.

Chiou WY, Chen CA, Lee MS, Lin HY, Li CY, Su YC, Tsai SJ, Hung SK.

Medicine (Baltimore). 2016 Nov;95(47):e5409.

15.

Caveolin-1 in the regulation of cell metabolism: a cancer perspective.

Nwosu ZC, Ebert MP, Dooley S, Meyer C.

Mol Cancer. 2016 Nov 16;15(1):71. Review.

16.

Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women.

Sun W, Lu J, Wu S, Bi Y, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Yang T, Yan L, Wan Q, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Wang T, Sun J, Xu M, Xu Y, Chen Y, Dai M, Zhang J, Zhang D, Lai S, Li D, Ning G, Wang W.

Am J Cancer Res. 2016 Oct 1;6(10):2334-2344. eCollection 2016.

17.

Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case-Control Study.

Peng XS, Xie GF, Qiu WZ, Tian YH, Zhang WJ, Cao KJ.

PLoS One. 2016 Oct 19;11(10):e0165131. doi: 10.1371/journal.pone.0165131. eCollection 2016.

18.

Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis.

Nokin MJ, Durieux F, Peixoto P, Chiavarina B, Peulen O, Blomme A, Turtoi A, Costanza B, Smargiasso N, Baiwir D, Scheijen JL, Schalkwijk CG, Leenders J, De Tullio P, Bianchi E, Thiry M, Uchida K, Spiegel DA, Cochrane JR, Hutton CA, De Pauw E, Delvenne P, Belpomme D, Castronovo V, Bellahcène A.

Elife. 2016 Oct 19;5. pii: e19375. doi: 10.7554/eLife.19375.

19.

Risk factors for cancer development in type 2 diabetes: A retrospective case-control study.

Dąbrowski M, Szymańska-Garbacz E, Miszczyszyn Z, Dereziński T, Czupryniak L.

BMC Cancer. 2016 Oct 10;16(1):785.

20.

The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review.

Rim SH, Guy GP Jr, Yabroff KR, McGraw KA, Ekwueme DU.

Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):579-589. Epub 2016 Oct 6. Review.

Supplemental Content

Support Center